Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Staar Surgical

This article was originally published in The Gray Sheet

Executive Summary

Board authorizes share buyback program under which the Monrovia, California-based ophthalmic surgery products firm will repurchase up to one million shares of its common stock over a two-year period. Shares in Staar have been trading for around $10 per share. The buyback program reflects Staar's "confidence" about its "long term prospects," the company says, adding that the share repurchases will benefit stockholders by reducing the number of Staar shares. The repurchases "will be made in the public market or through private sales" and "when or if such repurchases are deemed advisable." Staar currently has 13 mil. shares of common stock outstanding. The firm recently reported third quarter net income of $1.7 mil. -- representing an increase of 178% from last year's third quarter -- on revenues of $6.9 mil., up 46.8%
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003168

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel